315 related articles for article (PubMed ID: 4359884)
1. Imbalance in ornithine metabolism in hepatomas of different growth rates as expressed in behavior of L-ornithine:2-oxoacid aminotransferase (ornithine transaminase, EC 2.6.1.13).
Tomino I; Katunuma N; Morris HP; Weber G
Cancer Res; 1974 Mar; 34(3):627-36. PubMed ID: 4359884
[No Abstract] [Full Text] [Related]
2. Imbalance in ornithine metabolism in hepatomas of different growth rates as expressed in behavior of L-ornithine carbamyl transferase activity.
Weber G; Queener SF; Morris HP
Cancer Res; 1972 Sep; 32(9):1933-40. PubMed ID: 4345042
[No Abstract] [Full Text] [Related]
3. Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2).
Prajda N; Morris HP; Weber G
Cancer Res; 1976 Dec; 36(12):4639-46. PubMed ID: 187329
[TBL] [Abstract][Full Text] [Related]
4. Imbalance in ornithine metabolism in hepatomas of different growth rates as expressed in formation of putrescine, spermidine, and spermine.
Williams-Ashman HG; Coppoc GL; Weber G
Cancer Res; 1972 Sep; 32(9):1924-32. PubMed ID: 4345041
[No Abstract] [Full Text] [Related]
5. Ornithine oxoacid aminotransferase found in AH 130 ascites hepatoma cells.
Matsuzawa T; Sugimoto N; Sobue M; Ishiguro I
Biochim Biophys Acta; 1982 Feb; 714(2):356-60. PubMed ID: 7055619
[TBL] [Abstract][Full Text] [Related]
6. Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of glutamine-phosphoribosylpyrophosphate amidotransferase (amidophosphoribosyltransferase, EC 2.4.2.14).
Prajda N; Katunuma N; Morris HP; Weber G
Cancer Res; 1975 Nov; 35(11 Pt 1):3061-8. PubMed ID: 241484
[TBL] [Abstract][Full Text] [Related]
7. Behavior of opposing pathways of thymidine utilization in differentiating, regenerating, and neoplastic liver.
Ferdinandus JA; Morris HP; Weber G
Cancer Res; 1971 May; 31(5):550-6. PubMed ID: 4325837
[No Abstract] [Full Text] [Related]
8. The enzymology of methionine metabolism in rat hepatomas.
Grossman MR; Finkelstein JD; Kyle WE; Morris HP
Cancer Res; 1974 Apr; 34(4):794-800. PubMed ID: 4360840
[No Abstract] [Full Text] [Related]
9. Dihydroorotate dehydrogenase in liver and Morris hepatomas.
Sweeney MJ; Hoffman DH
Cancer Res; 1973 Feb; 33(2):394-6. PubMed ID: 4347471
[No Abstract] [Full Text] [Related]
10. Regulation of adenyl cyclase in hepatomas of different growth rates.
Allen DO; Munshower J; Morris HP; Weber G
Cancer Res; 1971 May; 31(5):557-60. PubMed ID: 4325838
[No Abstract] [Full Text] [Related]
11. Cyclic 3',5'-nucleotide monophosphate phosphodiesterase activity in hepatomas of different growth rates.
Rhoads AR; Morris HP; West WL
Cancer Res; 1972 Dec; 32(12):2651-5. PubMed ID: 4345399
[No Abstract] [Full Text] [Related]
12. Cyclic adenosine 3',5'-monophosphate phosphodiesterase activity in normal, differentiating, regenerating, and neoplastic liver.
Clark JF; Morris HP; Weber G
Cancer Res; 1973 Feb; 33(2):356-61. PubMed ID: 4347469
[No Abstract] [Full Text] [Related]
13. Effects of hydroxyurea and 6-mercaptopurine on growth and some aspects of carbohydrate metabolism in regenerating and neoplastic liver.
Lea MA; Sasovetz D; Musella A; Morris HP
Cancer Res; 1970 Jul; 30(7):1994-9. PubMed ID: 4318463
[No Abstract] [Full Text] [Related]
14. Responsiveness of glutamine-metabolizing enzymes in Morris hepatomas to metabolic modulations.
Wu C; Morris HP
Cancer Res; 1970 Nov; 30(11):2675-84. PubMed ID: 4321084
[No Abstract] [Full Text] [Related]
15. Expression mechanism of abnormality of ornithine aminotransferase level in Morris hepatomas.
Katunuma N; Kobayashi K
Adv Exp Med Biol; 1977 May 22-24; 92():117-23. PubMed ID: 205097
[No Abstract] [Full Text] [Related]
16. Studies on the turnover rates of ornithine aminotransferase in Morris hepatoma 44 and host liver.
Kobayashi K; Morris HP; Katunuma N
J Biochem; 1976 Nov; 80(5):1085-9. PubMed ID: 187580
[TBL] [Abstract][Full Text] [Related]
17. Alterations in enzymes of amino acid catabolism in livers of rats bearing the Morris 7800 hepatoma.
de Rosa G; Pitot HC
Cancer Res; 1978 Apr; 38(4):950-4. PubMed ID: 25132
[No Abstract] [Full Text] [Related]
18. Effects of exogenous histones upon the induction of tryptophan pyrrolase and tyrosine transaminase in liver and Morris hepatomas.
Strobel HW; Irvin JL; Morris HP
Cancer Res; 1970 Apr; 30(4):1075-80. PubMed ID: 4323347
[No Abstract] [Full Text] [Related]
19. Mitochondrial membrane-associated properties of Morris hepatomas.
Martin AP; Cornbleet PJ; Lucas FV; Morris HP; Vorbeck ML
Cancer Res; 1974 Apr; 34(4):850-8. PubMed ID: 4360844
[No Abstract] [Full Text] [Related]
20. Isozymes of pyruvate kinase in liver and hepatomas of the rat.
Farina FA; Shatton JB; Morris HP; Weinhouse S
Cancer Res; 1974 Jun; 34(6):1439-46. PubMed ID: 4363661
[No Abstract] [Full Text] [Related]
[Next] [New Search]
